ACORDA THERAPEUTICS INC - NOTE 1.750% 6/1

CUSIP: 00484MAA4

Q4 2015 13F Holders as of 31 Dec 2015

Type / Class
Debt / NOTE 1.750% 6/1
Market price (% of par)
115.2%
Total 13F principal
$340,214,000
Principal change
+$11,028,009
Total reported market value
$391,001,400
Number of holders
33
Value change
+$19,995,250
Number of buys
13
Number of sells
19

Quarterly Holders Quick Answers

What is CUSIP 00484MAA4?
CUSIP 00484MAA4 identifies 00484MAA4 - ACORDA THERAPEUTICS INC - NOTE 1.750% 6/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ACORDA THERAPEUTICS INC - NOTE 1.750% 6/1 as of Q4 2015

As of 31 Dec 2015, ACORDA THERAPEUTICS INC - NOTE 1.750% 6/1 was held by 33 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $340,214,000 in principal (par value) of the bond. The largest 10 bondholders included BAKER BROS. ADVISORS LP, OAKTREE CAPITAL MANAGEMENT LP, Calamos Advisors LLC, UBS ASSET MANAGEMENT AMERICAS INC, CNH PARTNERS LLC, Davidson Kempner Capital Management LP, WOLVERINE ASSET MANAGEMENT LLC, CAMDEN ASSET MANAGEMENT L P /CA, JPMORGAN CHASE & CO, and Polar Asset Management Partners Inc.. This page lists 33 institutional bondholders reporting positions for the Q4 2015 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.